387 related articles for article (PubMed ID: 33512975)
1. Electrocardiographic modifications and cardiac involvement in COVID-19 patients: results from an Italian cohort.
Matteucci A; Massaro G; Sergi D; Bonanni M; Stifano G; Matino M; Zerillo B; Rogliani P; Romeo F
J Cardiovasc Med (Hagerstown); 2021 Mar; 22(3):190-196. PubMed ID: 33512975
[TBL] [Abstract][Full Text] [Related]
2. Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin.
Cipriani A; Zorzi A; Ceccato D; Capone F; Parolin M; Donato F; Fioretto P; Pesavento R; Previato L; Maffei P; Saller A; Avogaro A; Sarais C; Gregori D; Iliceto S; Vettor R
Int J Cardiol; 2020 Oct; 316():280-284. PubMed ID: 32439366
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis.
Rossotti R; Travi G; Ughi N; Corradin M; Baiguera C; Fumagalli R; Bottiroli M; Mondino M; Merli M; Bellone A; Basile A; Ruggeri R; Colombo F; Moreno M; Pastori S; Perno CF; Tarsia P; Epis OM; Puoti M;
J Infect; 2020 Oct; 81(4):e11-e17. PubMed ID: 32652164
[TBL] [Abstract][Full Text] [Related]
4. Cardiac Corrected QT Interval Changes Among Patients Treated for COVID-19 Infection During the Early Phase of the Pandemic.
Rubin GA; Desai AD; Chai Z; Wang A; Chen Q; Wang AS; Kemal C; Baksh H; Biviano A; Dizon JM; Yarmohammadi H; Ehlert F; Saluja D; Rubin DA; Morrow JP; Avula UMR; Berman JP; Kushnir A; Abrams MP; Hennessey JA; Elias P; Poterucha TJ; Uriel N; Kubin CJ; LaSota E; Zucker J; Sobieszczyk ME; Schwartz A; Garan H; Waase MP; Wan EY
JAMA Netw Open; 2021 Apr; 4(4):e216842. PubMed ID: 33890991
[TBL] [Abstract][Full Text] [Related]
5. Effect of triple antimicrobial therapy on electrocardiography parameters in patients with mild-to-moderate coronavirus disease 2019.
Uğurlu Ilgın B; Akbulut Koyuncu İM; Kızıltunç E
Anatol J Cardiol; 2021 Mar; 25(3):184-190. PubMed ID: 33690133
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of electrocardiography findings in patients with coronavirus disease 2019: A retrospective study.
Yang D; Li J; Gao P; Chen T; Cheng Z; Cheng K; Deng H; Fang Q; Yi C; Fan H; Wu Y; Li L; Fang Y; Tian G; Pan W; Zhang F
Clin Cardiol; 2021 Jul; 44(7):963-970. PubMed ID: 33973673
[TBL] [Abstract][Full Text] [Related]
7. Absence of relevant QT interval prolongation in not critically ill COVID-19 patients.
Jiménez-Jáimez J; Macías-Ruiz R; Bermúdez-Jiménez F; Rubini-Costa R; Ramírez-Taboada J; Flores PIG; Gallo-Padilla L; García JDM; García CM; Suárez SM; Molina CF; López MÁ; Tercedor L
Sci Rep; 2020 Dec; 10(1):21417. PubMed ID: 33293554
[TBL] [Abstract][Full Text] [Related]
8. Electrocardiographic Features and Outcome: Correlations in 124 Hospitalized Patients With COVID-19 and Cardiovascular Events.
Nathala P; Salunkhe V; Samanapally H; Xu Q; Furmanek S; Fahmy OH; Deepti F; Glynn A; McGuffin T; Goldsmith DC; Petrey J; Ali T; Titus D; Carrico R; Ramirez J; Antimisiaris D; Clifford SP; Pahwa S; Roser L; Kong M; Huang J;
J Cardiothorac Vasc Anesth; 2022 Aug; 36(8 Pt B):2927-2934. PubMed ID: 35165040
[TBL] [Abstract][Full Text] [Related]
9. Corrected QT interval in hospitalized patients with coronavirus disease 2019: Focus on drugs therapy.
Ding J; Liu W; Guan H; Feng Y; Bao Y; Li H; Wang X; Zhou Z; Chen Z
Medicine (Baltimore); 2021 Jul; 100(28):e26538. PubMed ID: 34260531
[TBL] [Abstract][Full Text] [Related]
10. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
11. Arrhythmic safety of hydroxychloroquine in COVID-19 patients from different clinical settings.
Gasperetti A; Biffi M; Duru F; Schiavone M; Ziacchi M; Mitacchione G; Lavalle C; Saguner A; Lanfranchi A; Casalini G; Tocci M; Fabbricatore D; Salghetti F; Mariani MV; Busana M; Bellia A; Cogliati CB; Viale P; Antinori S; Galli M; Galiè N; Tondo C; Forleo GB
Europace; 2020 Dec; 22(12):1855-1863. PubMed ID: 32971536
[TBL] [Abstract][Full Text] [Related]
12. Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: an insight into the mechanisms of cardiac involvement.
Bertini M; Ferrari R; Guardigli G; Malagù M; Vitali F; Zucchetti O; D'Aniello E; Volta CA; Cimaglia P; Piovaccari G; Corzani A; Galvani M; Ortolani P; Rubboli A; Tortorici G; Casella G; Sassone B; Navazio A; Rossi L; Aschieri D; Rapezzi C
Europace; 2020 Dec; 22(12):1848-1854. PubMed ID: 32944767
[TBL] [Abstract][Full Text] [Related]
13. Cardiac involvement at presentation in patients hospitalized with COVID-19 and their outcome in a tertiary referral hospital in Northern Italy.
Ghio S; Baldi E; Vicentini A; Lenti MV; Di Sabatino A; Di Matteo A; Zuccaro V; Piloni D; Corsico A; Gnecchi M; Speciale F; Sabena A; Oltrona Visconti L; Perlini S;
Intern Emerg Med; 2020 Nov; 15(8):1457-1465. PubMed ID: 32960429
[TBL] [Abstract][Full Text] [Related]
14. Electrocardiographic findings at presentation and clinical outcome in patients with SARS-CoV-2 infection.
Lanza GA; De Vita A; Ravenna SE; D'Aiello A; Covino M; Franceschi F; Crea F
Europace; 2021 Jan; 23(1):123-129. PubMed ID: 33097933
[TBL] [Abstract][Full Text] [Related]
15. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Value of Electrocardiographic QRS Diminution in Patients Hospitalized With COVID-19 or Influenza.
Lampert J; Miller M; Halperin JL; Oates C; Giustino G; Nelson K; Feinman J; Kocovic N; Pulaski M; Musikantow D; Turagam MK; Sofi A; Choudry S; Langan MN; Koruth JS; Whang W; Miller MA; Dukkipati SR; Bassily-Marcus A; Kohli-Seth R; Goldman ME; Reddy VY
Am J Cardiol; 2021 Nov; 159():129-137. PubMed ID: 34579830
[TBL] [Abstract][Full Text] [Related]
17. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A
Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502
[TBL] [Abstract][Full Text] [Related]
18. Clinical and electrocardiographic characteristics at admission of COVID-19/SARS-CoV2 pneumonia infection.
Denegri A; Pezzuto G; D'Arienzo M; Morelli M; Savorani F; Cappello CG; Luciani A; Boriani G
Intern Emerg Med; 2021 Sep; 16(6):1451-1456. PubMed ID: 33398608
[TBL] [Abstract][Full Text] [Related]
19. The value of ECG changes in risk stratification of COVID-19 patients.
Bergamaschi L; D'Angelo EC; Paolisso P; Toniolo S; Fabrizio M; Angeli F; Donati F; Magnani I; Rinaldi A; Bartoli L; Chiti C; Biffi M; Pizzi C; Viale P; Galié N
Ann Noninvasive Electrocardiol; 2021 May; 26(3):e12815. PubMed ID: 33512742
[TBL] [Abstract][Full Text] [Related]
20. Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study.
Fernández-Ruiz M; López-Medrano F; Pérez-Jacoiste Asín MA; Maestro de la Calle G; Bueno H; Caro-Teller JM; Catalán M; de la Calle C; García-García R; Gómez C; Laguna-Goya R; Lizasoáin M; Martínez-López J; Origüen J; Pablos JL; Ripoll M; San Juan R; Trujillo H; Lumbreras C; Aguado JM
J Med Virol; 2021 Feb; 93(2):831-842. PubMed ID: 32672860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
